News and Announcements
Circadian Grants World-Wide Licence to Bio-Rad
- Published November 15, 2012 2:54AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) announces that its wholly owned subsidiary, Vegenics Pty Ltd, has entered into a non-exclusive worldwide licence agreement with one of the world’s leading providers of life science research and clinical diagnostics products, Bio-Rad Laboratories, Inc., (NYSE: BIO and BIOb), to market research assays for the detection of VEGF-C and/or VEGF-D in biological fluids.
Circadian owns extensive intellectual property rights for the use of VEGF-C and VEGF-D for diverse therapeutic applications and diagnosis. Circadian’s internal product programs are focused on the development of novel therapeutics for cancer and eye disease to market research products.
——-
To view the full article, please click the link below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
